The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies
Abstract
The purpose of these studies was to develop a metastatic osteosarcoma nude mouse model to evaluate the in vivo efficacy of new therapeutic compounds. Human SAOS-2 osteosarcoma cells (10(6) cells) were injected i.v. into nude mice. Cells isolated from a rare pulmonary metastases 6 months later were established (SAOS-LM1) in culture and re-injected. This procedure was repeated 5 additional times to produce the SAOS-LM6 cell line. Visible pulmonary nodules were present 8 weeks following i.v. injection of 10(6) SAOS-LM6 cells as compared to 17 weeks using SAOS-LM2 cells. Microscopic SAOS-LM6 pulmonary metastases were demonstrated at 6 weeks. Administration of adriamycin on week 9 resulted in regression of macroscopic SAOS-LM6 lung tumors. The ability of the model to be used to evaluate the effectiveness of a biologic agent against microscopic disease was also verified. It was concluded that this model can assess therapeutic efficacy and therefore, may have a role in investigating the potential of novel approaches aimed at eliminating pulmonary metastatic osteosarcoma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Companion cell lines with enhanced lung colonization capacity, such as SaOS2-LM7, MG63.3 and 143B 209,210,211 , have enabled the study of metastasis-driving mechanisms 50,212 .”
From Osteosarcoma (2022) · cites this paper as [209]
Citations
Cites
Selection of Successive Tumour Lines for Metastasis
Fidler, I. J. (1973) · Nature New Biology · doi:10.1038/newbio242148a0 · Cited by 1,365
Link, M. P., Goorin, A. M., Miser, A. W., Green, A. A., Pratt, C. B., Belasco, J. B., Pritchard, J., Malpas, J. S., Baker, A. R., Kirkpatrick, J. A., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142502 · Cited by 1,203
Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.
Eilber, F. R., Giuliano, A. E., Eckardt, J. J., Patterson, K., Moseley, S. H., & Goodnight, J. E. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.1.21 · Cited by 524
Morikawa, K., Walker, S. M., Nakajima, M., Pathak, S., Jessup, J. M., & Fidler, I. J. (1988) · PubMed · Cited by 474
Giavazzi, R., Campbell, D., Jessup, J. M., Cleary, K. R., & Fidler, I. J. (1986) · PubMed · Cited by 239
Putnam, J. B., Roth, J. A., Wesley, M. N., Johnston, M. R., & Rosenberg, S. A. (1983) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)60679-0 · Cited by 179
Berlin, Ö., Samid, D., Donthineni-Rao, R., Akeson, W. H., Amiel, D., & Woods, V. L. (1993) · PubMed · Cited by 150
Goorin, A. M., Shuster, J. J., Baker, A., Horowitz, M. E., Meyer, W. H., & Link, M. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.4.600 · Cited by 134
Efficacy of Liposomal Muramyl Tripeptide (CGP 19835A) in the Treatment of Relapsed Osteosarcoma
Kleinerman, E. S., Gano, J. B., Johnston, D. A., Benjamin, R. S., & Jaffe, N. (1995) · American Journal of Clinical Oncology · doi:10.1097/00000421-199504000-00001 · Cited by 116
Self-citationChen, D. S., Zhu, N., Hung, G., Skotzko, M. J., Hinton, D. R., Tolo, V. T., Hall, F. L., Anderson, W. F., & Gordon, E. M. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.14-1667 · Cited by 50
Research works printed but not linked: 5
- Jaffe N. Chemotherapy in osteosarcoma: Experimental and clinical progress in cancer chemotherapy. In Muggia FM(ed): Advances and Controversies. Boston: Martinus Nijhoff Publishers 1986; 223–33.
- Jia SF, Zwelling LA, McWatters A, ANT, Kleinerman ES. Interleukin-1? increase the cytotoxicity activity of etoposide against human osteosarcoma cells. J Exp Therap & Oncol (in press).
- Jia SF, Fan D, Kleinerman ES. Synergestic enhancement of adriamycin cytotoxicity against human osteosarcoma cells by TNFα. Pro Am Assoc Cancer Res 1992; 33: 3301.
- Samid D, Mandler R. Human osteosarcoma cells transformed by ras oncogenes: a new model for in vivo studies of pulmonary metastasis. Clinic Biotechnol 1989; 1: 21–6.
- Olson HM, Capen CC. Virus-induced animal model of osteosarcoma in the rat. Am J Pathol 1977; 86: 437–52.
Cited by
Sorted by citations
Items 101–148 of 148
Yang, Y., Huang, G., Zhou, Z., Fewell, J. G., & Kleinerman, E. S. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0042 · Cited by 14
Self-citationZhou, Z., Stewart, K. S., Yu, L., & Kleinerman, E. S. (2010) · Angiogenesis · doi:10.1007/s10456-010-9196-7 · Cited by 13
Self-citationHollomon, M. G., Patterson, L. L., Santiago‐O’Farrill, J. M., Kleinerman, E. S., & Gordon, N. B. (2020) · Journal of Cancer · doi:10.7150/jca.38721 · Cited by 12
Self-citationRibozyme Technology for Cancer Gene Target Identification and Validation
Li, Q., Tan, P., Ning, K., & Wong‐Staal, F. (2006) · Advances in cancer research · doi:10.1016/s0065-230x(06)96005-9 · Cited by 12
Du, L., Fan, Q., Tu, B., Yan, W., & Tang, T. (2014) · PubMed Central · Cited by 11
Osteosarcoma Phenotype Is Inhibited by 3,4-Methylenedioxy-β-nitrostyrene
Messerschmitt, P. J., Rettew, A. N., Schroeder, N. O., Brookover, R. E., Jakatdar, A., Getty, P. J., & Greenfield, E. M. (2012) · Sarcoma · doi:10.1155/2012/479712 · Cited by 11
Muff, R., Nigg, N., Gruber, P., Walters, D. K., Born, W., & Fuchs, B. (2007) · PubMed · Cited by 11
Mammalian models of bone sarcomas
Botter, S. M., Arlt, M., Born, W., & Fuchs, B. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416721-6.00030-3 · Cited by 10
Transcription factor c-Myb: novel prognostic factor in osteosarcoma
Říhová, K., Dúcka, M., Zambo, I. S., Vymětalová, L., Šrámek, M., Trčka, F., Verner, J., Drápela, S., Fedr, R., Suchánková, T., et al. (2022) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10145-4 · Cited by 10
Arsenic trioxide up-regulates Fas expression in human osteosarcoma cells
Yang, G., Li, X., Zhao, Z., & Wang, W. (2010) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.2010.13.028 · Cited by 10
Kiany, S., & Gordon, N. B. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3684-7_24 · Cited by 10
Tattersall, L., Davison, Z., & Gartland, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.62259-6 · Cited by 10
Fas Expression in Metastatic Osteosarcoma Cells Is Not Regulated by CpG Island Methylation
Huang, G., Koshkina, N. V., & Kleinerman, E. S. (2009) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504009789745638 · Cited by 9
Self-citationJia, S.-F., Guan, H., Duan, X., & Kleinerman, E. S. (2008) · PubMed · Cited by 9
Self-citationHarris, M. A., Hons, B., Shekhar, T. M., Coupland, L. A., Miles, M. A., & Hawkins, C. J. (2020) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2019.0172 · Cited by 9
Alvarez, M., Gutiérrez, L. M., Auzmendi, J., Correa, A., Lazarowski, A., & Bolontrade, M. F. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129522 · Cited by 8
Jia, S.-F., Zhou, R.-R., & Kleinerman, E. S. (2003) · Humana Press eBooks · doi:10.1385/1-59259-323-2:495 · Cited by 8
Self-citationHeim, T. E., Hankins, M. L., Belayneh, R., Douglas, N., Dinh, V., Kovvur, M., Boone, D. N., Ukani, V., Bhogal, S. S., Patel, V., et al. (2024) · Oncogene · doi:10.1038/s41388-024-02957-x · Cited by 7
Yu, P., Wen, J., Wang, J., Liang, J., Shen, Y., & Zhang, W. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.23 · Cited by 7
Kang, M. A., Rao, P. P., Matsui, H., & Mahajan, S. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147944 · Cited by 7
Barghi, F., Saadatzadeh, M. R., Dobrota, E. A., Shannon, H. E., Bailey, B. J., Young, C., Malko, R., Justice, R. E., Riyahi, N., Davis, C. M., et al. (2026) · Neoplasia · doi:10.1016/j.neo.2025.101266 · Cited by 6
LRRC15-CAR T Cells for the Treatment of Osteosarcoma
O'Reilly, C., Tuladhar, S., Nguyen, P. T., Sheppard, H., Koo, S. C., Chockley, P. J., Houke, H., Santiago, T., Tian, L., Jeschke, J., et al. (2026) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-2335 · Cited by 6
Tropomyosin isoforms encoded by TPM2 control the actin-bundling activity of fascin-1
Siatkowska, M., Robaszkiewicz, K., Rousová, A., Navrátil, J., Knopfová, L., Talián, G. C., Beneš, P., & Moraczewska, J. (2025) · Biological Research · doi:10.1186/s40659-025-00640-3 · Cited by 6
The Role of FAS Receptor Methylation in Osteosarcoma Metastasis
Sun, J. M., Chow, W.-Y., Xu, G., Hicks, J. M., Nakka, M., Shen, J. J., Ng, P. K. S., Taylor, A. M., Yu, A., Farrar, J. E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512155 · Cited by 6
Non-viral methods for gene transfer towards osteosarcoma therapy
Dass, C. R., & Choong, P. (2007) · Journal of drug targeting · doi:10.1080/10611860701231547 · Cited by 6
Protein Kinase C Epsilon and Genetic Networks in Osteosarcoma Metastasis
Goudarzi, A., Gökgöz, N., Gill, M., Pinnaduwage, D., Merico, D., Wunder, J. S., & Andrulis, I. L. (2013) · Cancers · doi:10.3390/cancers5020372 · Cited by 6
Kumar, S., Mokhtari, R. B., Yeger, H., & Baruchel, S. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.722077 · Cited by 6
Janeway, K. A., Gorlick, R. G., & Bernstein, M. L. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3431-5.00022-4 · Cited by 6
Gene and Virotherapy Against Osteosarcoma
Ketola, A. (2009) · Cited by 4
Murine and Canine Models of Appendicular Osteosarcoma
Fan, T. M. (2007) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph1401s37 · Cited by 3
Alvarez, M., Gutiérrez, L. M., Bayo, J., Cantero, M. J., García, M. G., & Bolontrade, M. F. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09315-w · Cited by 2
Animal Models of Malignant Primary Bone Tumors and Novel Therapeutic Approaches
Rousseau, J., Lamoureux, F., Picarda, G. G. A., Gouin, F., Trichet, V., & Rédiní, F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374895-9.00028-1 · Cited by 2
Haney, S. L., & Holstein, S. A. (2025) · Cancer Reports · doi:10.1002/cnr2.70390 · Cited by 1
Repurposing riluzole as an anti-osteosarcoma agent
Jung, O., Rajasekhar, V. K., Azeem, S. M., ChandThakuri, S., Norton, B., Healey, J. H., & Mahajan, S. S. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1508819 · Cited by 1
Rao‐Bindal, K. (2012) · Digital Commons-TMC (Texas Medical Center) · Cited by 1
Moghadam, A. R. (2018) · Mspace (University of Manitoba) · Cited by 1
Regulation of bax activation and apoptosis by src and acetylated mutant p53
Woods, N. T. (2008) · Digital Commons - University of South Florida (University of South Florida)
Models for Melanomas and Sarcomas
Worth, L. L., Kleinerman, E. S., & Bar‐Eli, M. (2005) · Wiley eBooks · doi:10.1002/0470025077.chap72
Self-citationThompson, L. (2009) · KU ScholarWorks (The University of Kansas)
Molecular Pathology of Bone and Soft Tissue Tumors
Ordóñez, J. L., Osuna, D., Madoz‐Gúrpide, J., & de Álava, E. (2016) · Springer eBooks · doi:10.1007/978-1-59745-458-2_34
Malek, A. V. (2013) · Springer eBooks · doi:10.1007/978-94-007-7835-1_6
Schott, C. R., Koehne, A. L., Sayles, L. C., Young, E. P., Luck, C., Yu, K., Lee, A. G., Breese, M. R., Leung, S. G., Xu, H., et al. (2024) · doi:10.1158/1078-0432.25232540
Rao, P. P., Herbert, C., Azeem, S. M., Gary, E., Ho, G., Munira, R., Askarifirouzja, H., Haimovitz‐Friedman, A., & Mahajan, S. S. (2025) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2025.06.3486
EGR1 Mediates Riluzole-Induced Apoptosis in Osteosarcoma via the Yap/p73-Bax Signaling AxisPreprint
Azeem, S. M., ChandThakuri, S., Rao, P. P., Abbasi, T., McFarlane, J., Munira, R., Porshe, S., Rajasekhar, V. K., Healey, J. H., & Mahajan, S. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.15.682608
Alvarez, M. J. P. V., Gutiérrez, L. M., Bayo, J., Cantero, M. J., Garcia, M., & Bolontrade, M. F. (2023) · Research Square · doi:10.21203/rs.3.rs-3471838/v1
Godinez, D. R. (2024) · eScholarship (California Digital Library)
Drug Screening of Sarcoma Cells: Finding Shared Sensitivities
Beird, H. C., Ho, C., Cárdenas-Zúñiga, R., Ahmed, A., Agyemang, C., Truong, D. D., Murgas, K. A., STEPHAN, C. C., Park, Y. S., Powell, R. T., et al. (2026) · Cancer Research Communications · doi:10.1158/2767-9764.crc-26-0142
Tong, Z., Yang, S., Chen, J., Guo, H., Zhao, P., & Wu, H. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103790
Metadata
- Authors
- Jia, S.-F., Worth, L. L., & Kleinerman, E. S.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Venue
- Clinical & Experimental Metastasis
- Published
- 1999-10
- Volume
- 17
- Issue
- 6
- Pages
- 501-506
- ISSN
- 0262-0898 (ISSN-L)
- 1573-7276
- OpenAlex
- W186831022
- Cited by
- 146
- References
- 20
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 4 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 10 · 2019: 5 · 2018: 7 · 2017: 5 · 2016: 6 · 2015: 4 · 2014: 4 · 2013: 5 · 2012: 8
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Clinical & Experimental Metastasis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-42992, CA-16672, R01CA042992, P30CA016672)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- osteosarcoma, lung metastasis, nude mouse model, Saos-2 cells, doxorubicin, treatment efficacy assessment, biologic agents
- MeSH terms
- Animals, Antineoplastic Agents, Disease Models, Animal, Doxorubicin, Drug Screening Assays, Antitumor, Etoposide, Humans, Lung Neoplasms, Mice, Nude, Neoplasm Transplantation, Osteosarcoma, Vinblastine, Cytokines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review